Novartis Challenges Puerto Rican Drug Oversight In High Court

Law360, Washington (July 18, 2013, 4:05 PM EDT) -- Novartis Pharmaceuticals Corp. asked the U.S. Supreme Court on Monday to stop Puerto Rico's Department of Consumer Affairs from regulating the prices at which it sells Puerto Rican wholesalers its products, saying the agency is inappropriately regulating interstate commerce with its price-setting actions.

Although Puerto Rican appellate courts have upheld DACO's ability to regulate Novartis' drug sales to wholesalers, the pharmaceutical company maintained in a petition for certiorari filed Monday that those transactions occur in Pennsylvania and New Jersey and fall outside the agency's regulatory jurisdiction....
To view the full article, register now.